FIELD: medicine, pharmaceutical industry, pharmacy.
SUBSTANCE: invention relates to the injection preparation of dalargin used as a medicinal agent in exacerbation of stomach ulcer and duodenum disease, acute pancreatitis and pancreas necrosis. The proposed injection isotonic 0.1% dalargin solution comprises dalargin, sodium chloride and injection water. Invention provides stability of properties in preparing and storage for 3 years, not less.
EFFECT: improved and valuable pharmaceutical properties of preparation.
1 tbl, 3 ex
Authors
Dates
2004-12-10—Published
2003-11-10—Filed